TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biomérieux Sweden AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
29,513
|
27,961
|
32,077 |
Financial expenses |
1
|
51
|
62 |
Earnings before taxes |
490
|
365
|
861 |
EBITDA |
633
|
678
|
1,226 |
Total assets |
12,238
|
10,898
|
12,625 |
Current assets |
11,221
|
9,719
|
11,016 |
Current liabilities |
7,681
|
6,090
|
7,676 |
Equity capital |
2,139
|
2,725
|
3,151 |
- share capital |
45
![]() |
45
|
49 |
Employees (average) |
31
|
27
![]() |
27 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
17.5%
|
25.0%
![]() |
25.0% |
Turnover per employee |
952
|
1,036
|
1,188 |
Profit as a percentage of turnover |
1.7%
|
1.3%
|
2.7% |
Return on assets (ROA) |
4.0%
|
3.8%
|
7.3% |
Current ratio |
146.1%
|
159.6%
|
143.5% |
Return on equity (ROE) |
22.9%
|
13.4%
|
27.3% |
Change turnover |
1,470
|
-1,517
|
5,523 |
Change turnover % |
5%
|
-5%
|
21% |
Chg. No. of employees |
4
|
0
|
1 |
Chg. No. of employees % |
15%
|
0%
|
4% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.